120 related articles for article (PubMed ID: 18031101)
1. Risks and benefits of low-dosage cyclosporin in rheumatoid arthritis.
Pasero G; Ferraccioli GF; Portioli I
BioDrugs; 1997 May; 7(5):376-85. PubMed ID: 18031101
[TBL] [Abstract][Full Text] [Related]
2. Is the control of disease progression within our grasp? Review of the GRISAR study. (Gruppo Reumatologi Italiani Studio Artrite Reumatoide).
Ferraccioli GF; Della Casa-Alberighi O; Marubini E; Priolo F; Mathieu A; Fantini F; Cutolo M; Pasero G
Br J Rheumatol; 1996 Sep; 35 Suppl 2():8-13. PubMed ID: 8810684
[TBL] [Abstract][Full Text] [Related]
3. Radiographic changes in the feet of patients with early rheumatoid arthritis. GRISAR (Gruppo Reumatologi Italiani Studio Artrite Reumatoide).
Priolo F; Bacarini L; Cammisa M; Cerase A; Ferrara R; Della Casa-Alberighi O
J Rheumatol; 1997 Nov; 24(11):2113-8. PubMed ID: 9375868
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials in rheumatoid arthritis: methodological suggestions for assessing radiographs arising from the GRISAR Study. Gruppo Reumatologi Italiani Studio Artrite Reumatoide.
Ferrara R; Priolo F; Cammisa M; Bacarini L; Cerase A; Pasero G; Ferraccioli GF; Alberighi OD; Antonellini A; Marubini E
Ann Rheum Dis; 1997 Oct; 56(10):608-12. PubMed ID: 9389222
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclosporin on joint damage in rheumatoid arthritis. The Italian Rheumatologists Study Group on Rheumatoid Arthritis.
Ferraccioli GF; Bambara LM; Ferraris M; Perpignano G; Cattaneo R; Porzio F; Accardo S; Mattara L; Zoppini A; Benucci M; Ostuni PA; Pasero G
Clin Exp Rheumatol; 1997; 15 Suppl 17():S83-9. PubMed ID: 9266138
[TBL] [Abstract][Full Text] [Related]
6. Progression in early rheumatoid arthritis.
Combe B
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
[TBL] [Abstract][Full Text] [Related]
7. The importance of early treatment for the prognosis of rheumatoid arthritis.
Kyburz D; Finckh A
Swiss Med Wkly; 2013; 143():w13865. PubMed ID: 24089023
[TBL] [Abstract][Full Text] [Related]
8. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
[TBL] [Abstract][Full Text] [Related]
9. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
10. Combination DMARD therapy including corticosteroids in early rheumatoid arthritis.
Möttönen TT; Hannonen PJ; Boers M
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S59-65. PubMed ID: 10589359
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab: a review of its use in rheumatoid arthritis.
Bang LM; Keating GM
BioDrugs; 2004; 18(2):121-39. PubMed ID: 15046527
[TBL] [Abstract][Full Text] [Related]
12. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
Simon LS
Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
[TBL] [Abstract][Full Text] [Related]
13. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S
Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420
[TBL] [Abstract][Full Text] [Related]
15. Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.
Nandi P; Kingsley GH; Scott DL
Curr Opin Rheumatol; 2008 May; 20(3):251-6. PubMed ID: 18388514
[TBL] [Abstract][Full Text] [Related]
16. Outcome of rheumatoid arthritis following adjunct statin therapy.
Das S; Mohanty M; Padhan P
Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
[TBL] [Abstract][Full Text] [Related]
17. Early rheumatoid arthritis: strategies for prevention and management.
Combe B
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
19. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
Culy CR; Keating GM
Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
Jacobs JW; Blaauw AA; Dijkmans BA; van Riel PL; Bijlsma JW
Ned Tijdschr Geneeskd; 2000 Jan; 144(5):211-6. PubMed ID: 10682647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
